Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000165090 | SCV000215795 | likely benign | Hereditary cancer-predisposing syndrome | 2021-11-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV000206535 | SCV000261348 | likely benign | Hereditary diffuse gastric adenocarcinoma | 2024-01-10 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000679568 | SCV000567139 | uncertain significance | not provided | 2024-11-15 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Observed in individuals with breast cancer (PMID: 31871109); This variant is associated with the following publications: (PMID: 25186627, 15235021, 22850631, 31871109) |
Counsyl | RCV000206535 | SCV000784986 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2017-03-22 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000679568 | SCV000806651 | uncertain significance | not provided | 2017-09-29 | criteria provided, single submitter | clinical testing | |
Mendelics | RCV000206535 | SCV000839092 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2018-07-02 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000165090 | SCV000911483 | uncertain significance | Hereditary cancer-predisposing syndrome | 2018-12-17 | criteria provided, single submitter | clinical testing | |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000679568 | SCV001134070 | likely benign | not provided | 2022-10-05 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001001975 | SCV001159782 | uncertain significance | not specified | 2018-07-05 | criteria provided, single submitter | clinical testing | The CDH1 c.1996A>C; p.Asn666His variant (rs150427791), to our knowledge, is not reported in the medical literature but is reported as a variant of uncertain significance in ClinVar (Variation ID: 185638). This variant is found in the African population with an overall allele frequency of 0.029% (7/24028 alleles) in the Genome Aggregation Database. The asparagine at codon 666 is weakly conserved and computational analyses (SIFT, PolyPhen-2) predict that this variant is tolerated. However, due to limited information regarding this variant, its clinical significance is uncertain at this time. |
Myriad Genetics, |
RCV000206535 | SCV004019529 | uncertain significance | Hereditary diffuse gastric adenocarcinoma | 2023-03-03 | criteria provided, single submitter | clinical testing | This variant is classified as a variant of uncertain significance as there is insufficient evidence to determine its impact on protein function and/or cancer risk. |